Myriad Genetics
MYGN
MYGN
223 hedge funds and large institutions have $1.7B invested in Myriad Genetics in 2016 Q3 according to their latest regulatory filings, with 32 funds opening new positions, 91 increasing their positions, 72 reducing their positions, and 57 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
223
Holders Change
-29
Holders Change %
-11.51%
% of All Funds
5.96%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
32
Increased
91
Reduced
72
Closed
57
Calls
$5.41M
Puts
$7.99M
Net Calls
-$2.58M
Net Calls Change
+$15.1M
Top Buyers
| 1 |
Acadian Asset Management
Boston,
Massachusetts
|
$57.2M |
| 2 |
Renaissance Technologies
New York
|
$60.3M |
| 3 |
Citadel Advisors
Miami,
Florida
|
$28.2M |
| 4 |
Neuberger Berman Group
New York
|
$24.2M |
| 5 |
NTC
North Tide Capital
Boston,
Massachusetts
|
$20.6M |
